Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-29

Clinical Trial Update: Efficacy, Safety and Tolerability of Sulthiame in Patients With Obstructive Sleep Apnea (OSA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy, safety, and tolerability of Sulthiame in patients with obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulthiame (sulthiame)

Snippet

Sponsor: Desitin Arzneimittel GmbH | Conditions: Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED